A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rivaroxaban 20 mg tablets relative to Xarelto 20 mg tablets, in healthy Thai volunteers under fed condition.
A randomized, open-labeled, multiple-dose, two-way crossover design with two-period, two-treatment, two-sequence steady-state bioequivalence study of Venlafaxine Hydrochloride Extended-Release Capsules 150 mg and Efexor XR 150 mg Capsules in healthy, adult, Thai volunteers under fed condition
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Venlafaxine Hydrochloride Extended-Release Capsules 150 mg and Efexor XR 150 mg Capsules in healthy, adult, Thai volunteers under fed condition
100 项与 Bio-innova Co., Ltd 相关的临床结果
0 项与 Bio-innova Co., Ltd 相关的专利（医药）
100 项与 Bio-innova Co., Ltd 相关的药物交易
100 项与 Bio-innova Co., Ltd 相关的转化医学
